PYVAX
Price
$16.37
Change
+$0.14 (+0.86%)
Updated
Jun 6 closing price
Net Assets
1.01B
RMFCX
Price
$57.64
Change
+$0.31 (+0.54%)
Updated
Jun 6 closing price
Net Assets
105.22B
Interact to see
Advertisement

PYVAX vs RMFCX

Header iconPYVAX vs RMFCX Comparison
Open Charts PYVAX vs RMFCXBanner chart's image
Payden Equity Income Adviser
Price$16.37
Change+$0.14 (+0.86%)
VolumeN/A
Net Assets1.01B
American Funds American Mutual R3
Price$57.64
Change+$0.31 (+0.54%)
VolumeN/A
Net Assets105.22B
PYVAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PYVAX vs. RMFCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVAX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. PYVAX (1.01B). RMFCX pays higher dividends than PYVAX: RMFCX (1.31) vs PYVAX (1.00). PYVAX was incepted earlier than RMFCX: PYVAX (14 years) vs RMFCX (23 years). PYVAX (1.01) is less costly to investors than RMFCX (0.91). PYVAX is a more actively managed with annual turnover of: 80.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than PYVAX: RMFCX (250) vs PYVAX (5000). RMFCX annual gain was more profitable for investors over the last year : 9.01 vs. PYVAX (-7.77). RMFCX return over 5 years is better than : 51.66 vs. PYVAX (5.49).
PYVAXRMFCXPYVAX / RMFCX
Total Expense Ratio1.010.91111%
Annual Report Gross Expense Ratio1.010.91111%
Fund Existence14 years23 years-
Gain YTD0.7305.91912%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B105B1%
Annual Yield % from dividends1.001.3176%
Returns for 1 year-7.779.01-86%
Returns for 3 years-4.9617.82-28%
Returns for 5 years5.4951.6611%
Returns for 10 years41.3970.4759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRI5.650.37
+7.01%
Stoneridge
WFRD48.371.54
+3.29%
Weatherford International plc
VICR45.260.95
+2.14%
Vicor Corp
LANDP19.52-0.02
-0.11%
Gladstone Land Corp
UNCY0.75-0.01
-1.92%
Unicycive Therapeutics